[综合性瘤学的证据,研究方法和质量标准:基础,共识和观点]
Isabell Ge1,2, Marie-Estelle Gaignard3, Sara Kohler4
1Frauenklinik und Brustklinik, Universitätsspital Basel, 4056 Basel, Schweiz.
综合性瘤学 (IO) 通过将传统医学与补充疗法结合起来,推进癌症治疗. 这需要新的研究方法和质量标准,以获得安全,有效,以患者为中心的结果.
科学领域:
- 在瘤学瘤学.
- 基于证据的医学基于证据的医学.
- 补充疗法 补充疗法 补充疗法
背景情况:
- 综合性瘤学 (IO) 将传统的癌症治疗与基于证据的补充程序相结合.
- 这种整合在定义证据,研究方法和癌症护理质量评估方面带来了独特的挑战.
研究的目的:
- 概述综合性瘤学的关键理论,方法和实践原则.
- 在基于证据的医学框架内检查证据的概念.
- 为以患者为中心的癌症护理提出新的研究设计和质量标准.
主要方法:
- 详细检查基于证据的医学的三个支柱.
- 讨论互补的研究设计:混合方法,实用研究,全系统方法和基于偏好的设计.
- 介绍法规和以实践为导向的质量标准.
主要成果:
- 探索多样化的研究设计如何产生有效的,以患者为中心的证据.
- 引入质量标准和达成共识的标准化过程.
- 通过瑞士综合性瘤学网络 (SNIO) 建立共同的标准,培训和研究策略.
结论:
- 在IO的发展需要重新评估证据和研究方法.
- 新的研究设计和质量标准对于安全,有效和以患者为中心的综合性癌症护理至关重要.
- 通过合作和标准化,SNIO倡议为推进IO提供了一个框架.
更多相关视频
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
10:49Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
Published on: January 21, 2019
相关概念视频
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
